EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Efficacy of Platelet-Rich Plasma Injection Therapy in Obese versus Non-Obese Patients with Knee Osteoarthritis: A Comparative Study

Juho Aleksi Annaniemi, Jüri Pere, Salvatore Giordano iD

Journal of Clinical Medicine · 28.04.2024 · 13 (9) · 2590

DOI: 10.3390/jcm13092590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.04.2024. Verfasst von Juho Aleksi Annaniemi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Welfare District of Forssa, 30100 Forssa, Finland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Obesity is a common comorbidity in knee osteoarthritis (KOA) patients. Platelet-Rich Plasma (PRP) injection therapy may mitigate KOA. To further clarify potential patient selection for PRP injection therapy, we compared the outcomes in patients with different body mass index (BMI).

Methods

A total of 91 patients with mild to moderate KOA were treated with three intra-articular PRP injections at 10 to 14-day intervals. Range of motion (ROM), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Visual Analogue Scale (VAS) were documented before and after the injections at 15 days, 6 months, 12 months, and at the last follow-up. Outcomes were compared between patients with a BMI over 30 kg/m2 (obese, n = 34) and under 30 kg/m2 (non-obese, n = 57).

Results

Significant difference during the follow-up was detected in WOMAC score at the last follow-up favouring BMI under 30 group [17.8 ± 18.8 versus 10.5 ± 11.7, p = 0.023]. The odds ratio (OR) in BMI over 30 kg/m2 group for total knee arthroplasty was 3.5 (95% CI 0.3–40.1, p = 0.553), and OR for any arthroplasty was 7.5 (95% CI 0.8–69.8, p = 0.085) compared to non-obese patients.

Conclusions

Obese patients benefitted from PRP injections in KOA but there is a minimal difference favouring non-obese patients in symptom alleviation in follow-up stages after 12 months. The risk of arthroplasty is higher for obese KOA patients.

Schlagwörter

Stichwörter der Autor:innen

PRPWOMACinjection therapyknee osteoarthritisobesityplatelet-rich plasma

Autor:innen und Institutionen

  • Department of Surgery, Welfare District of Forssa, 30100 Forssa, Finland.
  • Department of Surgery, Satasairaala Hospital, Satakunta Wellbeing Services County, 28500 Pori, Finland.
  • Department of Plastic and General Surgery, Turku University Hospital, The University of Turku, 20500 Turku, Finland.

ORCID-Profile: Salvatore Giordano

Zitieren

APA

Annaniemi, J. A., Pere, J., & Giordano, S. (2024). The Efficacy of Platelet-Rich Plasma Injection Therapy in Obese versus Non-Obese Patients with Knee Osteoarthritis: A Comparative Study. Journal of Clinical Medicine, 13(9), 2590. https://doi.org/10.3390/jcm13092590

Vancouver

Annaniemi JA, Pere J, Giordano S. The Efficacy of Platelet-Rich Plasma Injection Therapy in Obese versus Non-Obese Patients with Knee Osteoarthritis: A Comparative Study. Journal of Clinical Medicine. 2024;13(9):2590. doi:10.3390/jcm13092590

BibTeX
@article{Annaniemi2024,
  author = {Annaniemi, Juho Aleksi and Pere, Jüri and Giordano, Salvatore},
  title = {The Efficacy of Platelet-Rich Plasma Injection Therapy in Obese versus Non-Obese Patients with Knee Osteoarthritis: A Comparative Study},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {9},
  pages = {2590},
  doi = {10.3390/jcm13092590}
}
Kostenlos starten →